Modes of infection and oncogenesis by the Epstein-Barr virus.
about
The Role of microRNAs in the Pathogenesis of Herpesvirus InfectionEpstein-Barr virus (EBV) infection in Chinese children: a retrospective study of age-specific prevalence.The presence of Epstein-Barr virus significantly impacts the transcriptional profile in immunodeficiency-associated Burkitt lymphoma.Regulation of Epstein-Barr virus reactivation from latency.A Review of the Antiviral Role of Green Tea Catechins.Elimination of LMP1-expressing cells from a monolayer of gastric cancer AGS cellsDiscovery of a Novel Bat Gammaherpesvirus.Role of Feline Immunodeficiency Virus in Lymphomagenesis--Going Alone or Colluding?Severe Epstein-Barr virus infection in primary immunodeficiency and the normal host.Epstein-Barr Virus BKRF4 Gene Product Is Required for Efficient Progeny Production.The Epstein-Barr Virus BRRF1 Gene Is Dispensable for Viral Replication in HEK293 cells and Transformation.Knockdown of LMP1-induced miR-155 sensitizes nasopharyngeal carcinoma cells to radiotherapy in vitro.The Epstein-Barr Virus BDLF4 Gene Is Required for Efficient Expression of Viral Late Lytic Genes.Characterization of a Suppressive Cis-acting Element in the Epstein-Barr Virus LMP1 Promoter.Other Iatrogenic Immunodeficiency-associated Lymphoproliferative Disorder, Hodgkin type, following Epstein-Barr Viral Hepatitis in a Patient with Rheumatoid Arthritis.The Possible Effect of B-Cell Epitopes of Epstein–Barr Virus Early Antigen, Membrane Antigen, Latent Membrane Protein-1, and -2A on Systemic Lupus Erythematosus.Epigenetic Regulation of Tumor Suppressors by Helicobacter pylori Enhances EBV-Induced Proliferation of Gastric Epithelial Cells.BGLF2 Increases Infectivity of Epstein-Barr Virus by Activating AP-1 upon De Novo Infection.
P2860
Q26748350-94E47B6D-D2A0-4A1C-AE60-A6F953FC6BBCQ33734608-58FBF5BA-5BB9-438A-8EB6-DC670E0B7AF8Q35711180-7949865D-555E-4899-AF04-323494210A9BQ38208532-1073510E-711D-41B3-AADD-4D52D2CE487CQ38626136-977EC5FB-BD44-46E0-AD17-7B5C0471D803Q38705672-6A8E92E0-8D4E-4836-9132-C4411309472FQ38764358-B8318DA2-CCAD-4F6A-A50A-B55B92D6690EQ38795312-5393E5A0-4319-43C4-BA8F-A1582D4554CEQ38982455-B19212D7-4195-456A-8BDE-04416E7949DAQ40042387-7ABE926E-24BF-4FD5-B3A7-7FC6FB43CC25Q40114050-7EA0087C-4406-43BE-9DE4-B04CDC6FE51BQ40500515-EE384009-138F-4C3D-8ACE-256ADAFD3801Q41094782-A098919D-AC9F-4097-9CDE-8B4CA6207AF7Q45323690-389E2621-B7B0-417C-9E9E-0192DB24160CQ47560339-754553FC-4BD4-4E5B-9563-B7BC5CA801F2Q50347150-E1E17E8D-082D-490F-84B0-88371D12631DQ52565524-30DDF17F-2D5C-4A8F-AE6A-78F29F3BB194Q52716630-2A261331-338E-47A4-B8FF-59468EC8883E
P2860
Modes of infection and oncogenesis by the Epstein-Barr virus.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Modes of infection and oncogenesis by the Epstein-Barr virus.
@en
type
label
Modes of infection and oncogenesis by the Epstein-Barr virus.
@en
prefLabel
Modes of infection and oncogenesis by the Epstein-Barr virus.
@en
P2860
P356
P1476
Modes of infection and oncogenesis by the Epstein-Barr virus
@en
P2093
Takayuki Murata
P2860
P304
P356
10.1002/RMV.1786
P577
2014-02-28T00:00:00Z